Advanced Technologies & Treatments for Diabetes 2024, Florencia – sumár z kongresu

Czech version

Authors: Peter Novodvorský ^1,2,3
Authors‘ workplace: metabolické centrum s. r. o., Trenčín ¹; Centrum diabetologie IKEM, Praha ²; Department of Oncology and Metabolism, Medical School, University of Sheffield, United Kingdom ³
Published in: Diab Obez 2024; 24(1): 82-84
Category: News

Sources

Lee TT, Collett C, Bergford S et al. Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes. N Engl J Med 2023; 389(17): 1566–1578. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa2303911>.

Forlenza GP, McVean J, Beck RW et al. Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial. JAMA 2023; 329(12): 990–999. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2023.2064>.

Kovatchev BP, Frasquet AC, Pryor EC et al. Neural-Net Artificial Pancreas: A Randomized Crossover Trial of a First-in-Class Automated Insulin Delivery Algorithm. Diabetes Technol Ther. 2024.Diabetes Technol Ther 2024. Dostupné z DOI: <http://dx.doi.org/10.1089/dia.2023.0469>.

Battelino T, Alexander CM, Amiel SA et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol 2023; 11(1): 42–57. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213–8587(22)00319–9>.